Cigna Group
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $5.96B | $3.43B | $5.16B | $6.78B | $5.42B | $8.49B | $5.12B | $2.65B |
| Depreciation & Amortization | $2.78B | $2.78B | $3.04B | $2.94B | $2.92B | $2.80B | $3.65B | $695.0M |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | $1.74B | $1.70B | $1.82B | $1.88B | $2.00B | $1.98B | $2.95B | $235.0M |
| Stock-Based Compensation | — | — | — | — | — | — | — | — |
| Net Cash from Operating Activities | $9.60B | $10.36B | $11.81B | $8.66B | $7.19B | $10.35B | $9.49B | $3.77B |
| Investing Activities | ||||||||
| Capital Expenditures | — | — | — | — | — | — | $1.05B | $528.0M |
| Business Acquisitions | $597.0M | $131.0M | $447.0M | $0 | $1.83B | $139.0M | $153.0M | $24.46B |
| Net Cash from Investing Activities | $-4.41B | $-2.10B | $-5.17B | $3.10B | $-3.61B | $2.98B | $-734.0M | $-26.38B |
| Financing Activities | ||||||||
| Dividends Paid | $1.61B | $1.57B | $1.45B | $1.38B | $1.34B | $15.0M | $15.0M | — |
| Stock Repurchases | $3.62B | $7.03B | $2.28B | $7.61B | $7.74B | $4.04B | $1.99B | $342.0M |
| Net Cash from Financing Activities | $-6.42B | $-7.65B | $-4.29B | $-11.24B | $-8.21B | $-8.53B | $-7.19B | $23.52B |
| Net Change in Cash | $-1.20B | $594.0M | $2.36B | $428.0M | $-4.70B | $4.83B | $1.56B | $883.0M |
| Free Cash Flow | — | — | — | — | — | — | $8.44B | $3.24B |